Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.
Texte intégral
Figure
Documents relatifs
“Rosiglitazone is indicated only in oral combination treatment of Type 2 diabetes mellitus in patients with insufficient glycaemic control despite maximal tolerated dose of
In this study, we describe how CED differs from other conditional coverage agreements, provide a brief history of CED, describe several real-world examples of CED from dif-
Since urine samples and prescription drug could not be distinguished by means of statistical analysis, carbon isotopic effects and subsequent influence on δ 13 C values through
Both simulations show in multiple events the reversible formation and disruption of -helical secondary struc- ture [similar to the NMR model structure for the ordered state of
The hierarchical co-primary objectives of this study were, first, to assess if sedation with dexmedetomidine (higher doses and/or longer duration than approved) is as good as
The following direct costs are considered, according to a collec- tive perspective: costs of care performed routinely, costs of the management of acute opportu- nistic infections,
Adopting a health sector perspective in Cameroon, Cote-d’Ivoire, and Senegal, a decision tree model was developed to compare 12 testing strategies with the following characteris-
The performance of each line feeding mode is measured as a periodic total cost that includes preparation, picking for the assembly, transportation and storage